Kamada Y, Arima N, Hayashida M, Nakamura D, et al. Prediction of the risk for graft versus host disease after allogeneic hematopoietic stem cell transplantation in patients treated with mogamulizumab. Leuk Lymphoma 2022 Feb 27:1-7. doi: 10.1080/10428194.2022.2043300.
PMID: 35225126